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Abstract
Background: Recombinant adenovirus vectors and transfection agents comprising cationic lipids are widely used as gene
delivery vehicles for functional expression in cultured cells. Consequently, these tools are utilized to investigate the effects
of functional over-expression of proteins on insulin mediated events. However, we have previously reported that cationic
lipid reagents cause a state of insulin unresponsiveness in cell cultures. In addition, we have found that cultured cells often
do not respond to insulin stimulation following adenovirus treatment. Infection with adenovirus compromises vital
functions of the host cell leading to the activation of protein kinases central to insulin signalling, such as protein kinase B/
Akt. Therefore, we investigated the effect of adenovirus infection on insulin unresponsiveness by means of Akt activation
in cultured cells. Moreover, we investigated the use of baculovirus as a heterologous viral gene delivery vehicle to
circumvent these phenomena. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications
of this viral system in gene delivery has greatly expanded and one advantage is the virtual absence of cytotoxicity in
mammalian cells.
Results: We show that infection of human neuroblastoma SHSY-5Y and liver C3A cells with recombinant adenovirus
results in the activation of Akt in a dose dependent manner. In addition, this activation makes treated cells unresponsive
to insulin stimulation as determined by an apparent lack of differential phosphorylation of Akt on serine-473. Our data
further indicate that the use of recombinant baculovirus does not increase the phosphorylation of Akt in SHSY-5Y and C3A
cells. Moreover, following infection with baculovirus, SHSY-5Y and C3A cells respond to insulin by means of
phosphorylation of Akt on serine-473 in the same manner as uninfected cells.
Conclusion: Widely-used adenovirus vectors for gene delivery cause a state of insulin unresponsiveness in human SHSY-
5Y and C3A cells in culture due to the activation of central protein kinases of the insulin signalling pathway. This
phenomenon can be avoided when studying insulin signalling by using recombinant baculovirus as a heterologous viral
expression system. In addition, our data may contribute to an understanding of the molecular mechanisms underlying
baculovirus infection of human cells.
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Background
The insulin receptor (IR) is a heterotetrameric protein
tyrosine kinase whose kinase activity is activated upon
binding of insulin [1]. Several aspects of cell metabolism
and physiology are controlled and regulated by insulin,
and through interactions with the IR at the cell surface,
insulin causes the modulation of several interacting signal
transduction pathways subsequently leading to physio-
logical responses at the cellular level. The function of the
transduction pathways is to coordinate the activation or
inactivation of proteins in response to external stimuli.
Moreover, pleiotropic [2] and differential properties, both
in terms of common steps in their pathways [3] as well as
in differential activation [4] make signalling diverse. Pro-
tein phosphorylation and dephosphorylation play a
major role in intracellular signal transduction regulation
[5] and the phosphorylation state of a target protein is
dependent on the equilibrium between these activities.
Disturbances in any element of such regulatory systems
may lead to pathological conditions such as diabetes type
II and cancer and are therefore the subject of extensive
studies. In our research work we have performed various
studies which investigate the effects of over-expression of
a variety of different proteins on insulin-mediated events
in cells in culture. The outcome of such studies places an
emphasis on the ability to perform quantitative analyses
with low back-ground noise.
Gene delivery into mammalian cells for protein over-
expression and assessment of gene function involves viral
as well as non-viral methods. Commonly, the non-viral
methods comprise plasmid transfection with cationic lip-
ids or polymers [6]. In contrast, viral transduction utilises
gene transfer by infection of host cells with a modified
virus (reviewed in [7]). Advantages of using viral delivery
systems are related to less cell membrane damage and a
higher degree of transduction efficiency as compared to
the non-viral methods, thus providing viruses as excellent
tools for gene delivery to study cell biological processes.
Nevertheless, the use of viral delivery systems may suffer
from lengthy construction time requiring transfection
steps, cloning of producer cell lines to generate virus
stocks, stock amplification and purification. In addition,
homologous viral systems of animal or human origin,
such as the commonly utilized adenovirus expression sys-
tem, must be engineered to remove functions involved in
the expression of viral genes and viral replication [8]. In
addition, the use of recombinant viruses for gene delivery
comprises vital functions such as cell membrane adhesion
and entry, cytoplasmic transport, replication of viral
genome (DNA viruses), and subsequently transcription
and translation of the gene of interest (adenovirus endo-
cytosis reviewed in [9]). It is well documented that such
mechanisms involved in adenovirus infection and host
inflammatory response modulate several host cell signal-
ling pathways [10] which therefore may interfere with
functional mechanisms in study. For example, incoming
adenoviruses have been shown to up-regulate two distinct
cell signalling pathways leading to the activation of
integrins and cAMP-dependent proteinkinase A (PKA),
and p38/MAP kinase pathways, respectively [11]. Down-
stream of p38/MAP kinase, MAPKAP kinase 2 (MK2) was
shown to be activated upon adenovirus infection [11].
Interaction of adenovirus with αv integrins induces the
activation of phosphatidylinositol 3-kinase (PI3-kinase)
which triggers endocytosis [12,13]. Downstream of PI3-
kinase, both protein kinase B/Akt and ERK/MAP kinase
signalling pathways have been shown to be activated in a
dose-dependent manner within minutes following aden-
ovirus infection [14,15]. In addition, the phosphorylation
of glycogen synthase kinase (GSK)-3β and nuclear trans-
location of the p65 subunit of NF-κB, both downstream
targets of the PI3-kinase/Akt pathway, was demonstrated
in adenovirus-infected corneal fibroblasts [16]. Further-
more, it was shown that adenovirus overrides cellular pro-
tein translation in a process involving the downstream
activation of mTOR [17]. Similarly, downstream of the
p38/MAP kinase pathway, MAP kinase interacting kinase
1 (Mnk1) [18,19] was displaced from the eukaryotic initi-
ation factor 4F (eIF4F) complex in HEK293 cells, thereby
blocking the phosphorylation of eIF4E by Mnk1 and the
subsequent translation of cellular mRNA in HEK293 cells
[20].
Over the past 20 years, the insect cell/baculovirus expres-
sion vector system, BEVS [21], has become an important
tool for laboratory as well as for industrial scale expres-
sion of various heterologous proteins [22-24]. BEVS has
also emerged as a versatile and powerful expression sys-
tem for functional studies of proteins such as protein
kinases [25] and G protein-coupled receptors [26], for
protein-protein interactions [27], cell based screening
[28] and for viral surface display [29]. Moreover, BEVS has
been shown to serve as an efficient gene-transfer vehicle in
mammalian cells (termed BacMam) for transient and sta-
ble expression of recombinant proteins [30]. Lately, there
has been an increasing interest in the use of baculovirus
for gene delivery in mammalian cells for protein produc-
tion, functional expression, and gene therapy (reviewed in
[31-33]. For example, the BacMam expression system was
recently used to study estrogen receptor function in oste-
osarcoma cells [34], functional characterization of a KATP
channel protein in CHO and HEK293 cells [35], and for
RNA interference in human primary cells [36]. It has also
been developed for the application of nuclear- [37,38]
and G protein-coupled-receptor [39, 40] drug discovery.
This interest has been enthused by the relative ease of con-
struction and propagation of recombinant baculovirus
vectors, restricted host range for viral replication and viralBMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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gene expression, combined with high transduction effi-
ciency and no to low observable cytotoxicity in a wide
range of mammalian cell types (reviewed in [41]). The use
of specially engineered recombinant baculoviruses as effi-
cient vehicles for gene transfer into mammalian cells is
rapidly emerging as a powerful system for a variety of
applications.
In this work we have investigated the use of engineered
Autographa californica multiple nuclear polyhedrosis virus
(AcMNPV) as a gene delivery tool to study insulin medi-
ated events in human neuroblastoma SHSY-5Y and
hepatic C3A cells. Previously, investigating the effects of
over-expression of proteins on insulin mediated events,
we found that cells in culture often became resistant to
stimulation with insulin subsequent to treatment with
transfection agents comprised of cationic lipid prepara-
tions [42]. This was shown to be caused by an induced
state of insulin unresponsiveness due to insulin receptor
activation and subsequent down-regulation. Similarly, we
have found that cells in culture often become resistant to
stimulation with insulin subsequent to treatment with
adenovirus vectors (unpublished). In the present work we
highlight the fact that adenovirus infection of human cells
in culture involves the activation of PI3-kinase and subse-
quently the downstream activation of Akt. The PI3-kinase/
Akt pathway is central to insulin mediated signalling and
Akt is central for cellular responses mediated by insulin
(reviewed in [43]). We show that adenovirus mediated
gene transfer in human neuroblastoma SHSY-5Y and liver
C3A cells cause a dose dependent phosphorylation of Akt
and that this makes the cells unresponsive to insulin. Fur-
thermore, we suggest that this phenomenon can be
avoided by using recombinant AcMNPV baculovirus
mediated gene transfer when studying insulin signalling
in human neuroblastoma or liver cells.
Results
Infection of human neuroblastoma SHSY-5Y and liver C3A 
cells with recombinant adenovirus induces Akt-Ser473 
phosphorylation
Adenoviral gene delivery is commonly utilized for func-
tional over-expression and characterization of a gene-of-
interest in mammalian cells. However, it is widely recog-
nized that viral infection of human cell lines with homol-
ogous adenovirus vectors induces the activation of
phosphatidylinositol 3-kinase (PI3-kinase), subsequently
leading to the phosphorylation of protein kinase B/Akt on
Serine 473 [12,11,14]. Akt is central for cellular responses
mediated by insulin (reviewed in [43]) and activation of
Akt is hence used as a common marker in insulin signal-
ling. Therefore, while studying the impact of over-expres-
sion of various protein kinases on insulin signalling in
experimental human cell lines, we investigated the influ-
ence of recombinant adenovirus on Akt phosphorylation
in SHSY-5Y and C3A cells. Cultured cells were first
infected with recombinant adenovirus expressing green
fluorescent protein (AdGFP) as a model protein, and
phosphorylation of Akt was studied with specific Ser473-
phosho-Akt antibodies (ELISA and western blot). Viral
titration was performed at multiplicity of infection (MOI)
between 10 and 50 and GFP expression was determined
48 hours post infection (p.i.) by flow cytometry gated for
intact adenovirus infected cells. Figure 1 displays side scat-
ter against forward scatter for SHSY-5Y and C3A cells
infected with AdGFP at MOI 10, 20, and 50, respectively.
The resulting transduction efficiencies were determined
from expression histograms of the populations of intact
cells (illustrated as the upper cell population in respective
scatter plot) which are shown in the lower panels of Figure
1 for each respective cell line, and was found to be 26.5,
58.6, and 86.9 % for SHSY-5Y cells, and 26.2, 47.8, and
67.3 % for C3A cells infected at MOI 10, 20, and 50,
respectively.
Next, the influence on Akt phosphorylation following
adenovirus transduction was investigated. As anticipated,
the degree of phosphorylation of Akt increased upon ade-
novirus infection and this increase was dose-dependent
when both SHSY-5Y as well as C3A cells were subjected to
adenovirus infection. The degree of phosphorylation
increased 4 and 5-fold for SHSY-5Y cells, and 1.8 and 2.4-
fold for C3A cells, infected at MOI 10 and 50, respectively,
as determined with an ELISA assay measuring phospho-
serine 473 in PKB. These results were confirmed under
various experimental conditions and are summarized in
the upper part of Table 1 for AdGFP. To further validate
the results, the data obtained with the commercial ELISA
were verified with western blot using specific Ser473-
phosho-Akt antibodies. Again, phosphorylation on serine
473 in infected but unstimulated cells was seen, thus con-
firming the activation of PKB by adenovirus infection
measured by two different methods (Figure 2, lane 1 and
3). Taken together, the results from these experiments
show that when transduced with adenovirus up to MOI
50, SHSY-5Y and C3A cells respond with an increased
phosphorylation of Ser473 Akt indicating that using ade-
novirus as a gene transfer vehicle in SHSY-5Y and C3A
cells may influence the cells responsiveness to insulin
treatment.
Baculovirus mediated gene transduction and recombinant 
protein expression do not influence the level of 
phosphorylation of Akt in human SHSY-5Y and C3A cells
The use of engineered baculovirus as a gene transfer vehi-
cle in mammalian cells has emerged as a powerful tool for
several applications. One advantage of using this heterol-
ogous viral system is the virtual absence of endogenous
viral gene expression and cytotoxicity in mammalian cells
[32]. In view of the results obtained above, we thereforeBMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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investigated the use of baculovirus as a potential tool for
gene delivery in human cell lines used to study insulin sig-
nalling. High efficiency baculovirus transduction of vari-
ous liver [44,45] and neural cell lines [46] has been
established previously. However, the use of the human
neuroblastoma SHSY-5Y cells has to our knowledge not
been reported and transduction efficiency and expression
of reporter protein in SHSY-5Y cells was therefore first
confirmed. Similar to that for adenovirus (AdGFP), a viral
construct containing GFP under the control of a cytomeg-
alovirus promoter (CMV) was first constructed (BacGFP).
Recombinant virus was propagated in Sf9 insect cells and
prepared as described in the Methods section. Adherent
cultures of SHSY-5Y cells were infected with BacGFP and
expression of reporter protein was confirmed by fluores-
cence microscopy 24 hours p.i. (data not shown). For
quantification and titration of transduction ratio, the cells
were infected at MOI's between 50 and 10000 and for
practical reasons the transduction efficiency (as % GFP
expressing cells) and expression level (as relative units,
R.U.) were analysed 48 hours p.i. using a chip-based flow
cytometry application [53]. Without further optimisation
of the infection and expression conditions, the transduc-
tion ratio increased in a dose dependent manner with
increased MOI to a maximum of 35 % (Table 2). How-
ever, when butyrate was added to the cells to enhance pro-
tein expression at a final concentration of 10 mM, the
relative amount of GFP expressing-, and thus apparently
transduced cells, was significantly increased from about
35 to 82 %. In addition, the maximum relative mean
expression level increased more than 4-fold in the SHSY-
5Y cells when butyrate was present (Table 2). Butyrate is a
Transduction of SHSY-5Y and C3A cells 48 hours post infection with recombinant adenovirus expressing green fluorescent  protein Figure 1
Transduction of SHSY-5Y and C3A cells 48 hours post infection with recombinant adenovirus expressing 
green fluorescent protein. Flow cytometry scatter plots of SHSY-5Y and C3A cells infected at MOI 10, 20, and 50; cells 
corresponding to the upper areas of the respective scatterplot (upper panels) were analysed for transduction efficiency by GFP 
expression (lower panels).BMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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histone deacetylase (HDAC) inhibitor, inducing a hyper-
acetylation of chromatin and enhancement of transcrip-
tion. The importance of the chromatin state of the
baculovirus genome in the transduced cells for transgene
expression and the role of HDAC inhibitors has been well
described [30,47] and will not be further discussed.
Besides the more thorough investigation of SHSY-5Y cells,
Chinese Hamster Overy cells (CHO.hIR) stably expressing
the human insulin receptor [42], Human Embryonic Kid-
ney cells (HEK293), and rat Fao- and human C3A hepatic-
derived cell lines, were screened for the ability to be trans-
duced by BacGFP (Table 3). This screen indicated that the
CHO.hIR and the human HEK293 cell lines were easily
transduced by BacGFP as previously been reported by oth-
ers [30]. However, under our conditions butyrate was
required to confirm efficient transduction in the CHO.hIR
cell line. Whether this was conditional or caused by the
heterologous IR was not further investigated. The human
hepatic-derived C3A cell line was also easily transduced
by BacGFP and similarly to HEK293 and CHO.hIR,
butyrate enhanced the expression of GFP and thus the
apparent transduction ratio. By contrast, only minor GFP
expression was detected in the rat hepatic-derived cell line
Fao (Table 3) and was essentially unaffected by the addi-
tion of butyrate. Thus rat FAO hepatoma cells appear to be
relatively resistant to BacMam viral transduction.
Next, the influence of baculovirus infection and recom-
binant protein expression on the phosphorylation of Akt
was investigated. In these studies SHSY-5Y and C3A cells
were infected with BacGFP and total and phosphorylated
Akt were analysed using an Akt specific ELISA, as previ-
ously reported with AdGFP. Baculovirus titres of 1000 and
10000 were chosen to achieve experimentally desired
transduction ratios. In contrast to cells infected with ade-
novirus at MOI 10 and 50, where PKB activation was
observed (Table 1), cells transduced with BacMam at MOI
1000 and 10000 showed no apparent increase in PKB
phosphorylation. This was true for both SHSY-5Y and
C3A cells (Table 1; BacGFP). Taken together, the results
from the experiments summarized in Table 1 show that
when transduced with adenovirus at MOI 10 and 50,
SHSY-5Y and C3A cells respond with an increased phos-
phorylation of Ser473 Akt (which is not accompanied by
an increased expression of Akt) and that this can be
avoided by utilizing baculovirus transduction, at MOI's as
high as 10000.
Baculovirus mediated gene transduction and recombinant 
protein expression do not impair insulin mediated 
phosphorylation of Akt in SHSY-5Y and C3A cells
Since infection of SHSY-5Y and C3A cells with baculovi-
rus apparently did not influence the phosphorylation of
Akt, the response to insulin following infection was inves-
tigated. First the response to insulin of uninfected cells
was determined. SHSY-5Y and C3A cells were incubated
with 100 nM insulin for 10 and 30 minutes, respectively
and the phosphorylation of Akt was determined with
phospho-specific ELISA (Figure 3; no virus). The response
was most pronounced for SHSY-5Y cells with a transient
4.9-fold increase in Akt phosphorylation 10 minutes after
addition of insulin which remained 3.1 – fold elevated
after 30 minutes (Figure 3A and 3C, no virus). This data
was again verified for SHSY-5Y cells with western blot
using specific Ser473-phosho-Akt antibodies (Figure 2,
lane 1 and 2). The C3A cells also responded to insulin
Table 1: Influence of transduction with recombinant adenovirus (AdGFP) or baculovirus (BacGFP) on phosphorylation of Akt Ser-473 
in SHSY-5Y and C3A cells.
Cells Virus MOI Akt (A.U.) pSer473 Akt (A.U.) pSer473 Akt/Akt
10 min 30 min 10 min 30 min 10 min 30 min
SHSY-5Y AdGFP 0 2.73 2.46 0.20 0.32 0.07 0.13
SHSY-5Y AdGFP 10 2.60 2.24 0.81 0.90 0.31 0.40
SHSY-5Y AdGFP 50 2.25 2.03 0.80 1.30 0.35 0.64
C3A AdGFP 0 0.80 0.95 0.15 0.24 0.19 0.25
C3A AdGFP 10 0.72 0.64 0.25 0.45 0.35 0.70
C3A AdGFP 50 0.69 0.59 0.31 0.54 0.45 0.91
SHSY-5Y BacGFP 0 2.64 2.56 0.25 0.36 0.09 0.14
SHSY-5Y BacGFP 1000 2.74 2.62 0.20 0.40 0.07 0.15
SHSY-5Y BacGFP 10000 2.86 2.69 0.22 0.36 0.08 0.13
C3A BacGFP 0 0.94 0.79 0.16 0.20 0.17 0.25
C3A BacGFP 1000 1.04 0.84 0.15 0.20 0.15 0.23
C3A BacGFP 10000 1.09 0.89 0.15 0.23 0.14 0.26
Time notations refer to time of incubation at experimental conditions determined by the ELISA method.BMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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albeit to a lower degree reaching a sustainable 1.6 – fold
increase in Akt phosphorylation after 10 and 30 minutes
incubation, respectively (Figure 3B and 3D, no virus).
Next, the effect of insulin stimulation of cells infected
with adenovirus and baculovirus, respectively, were inves-
tigated. As previously found for SHSY-5Y cells infected
with adenovirus (Table 1; Figure 2, lane 1 and 3), infec-
tion with AdGFP at MOI10 and 50 in the absence of insu-
lin gave a dose dependent increase in Akt
phosphorylation (Figure 3A and 3C). In addition, when
the cells were incubated in the presence of 100 nM insulin
for 10 minutes no additional phosphorylation of Akt was
obtained (Figure 3A; Figure 2, lane 3 and 4). After 30 min-
utes of incubation with 100 nM insulin, Akt was further
activated 1.6 and 1.7-fold over the activation already
induced by adenovirus infection (Figure 3C). By contrast,
SHSY-5Y cells infected with baculovirus showed no sign
of basal Akt phosphorylation after 10 or 30 minutes (Fig-
ure 3A and 3C). Moreover, upon insulin stimulation of
baculovirus infected cells, the response was analogous to
that for non infected cells incubated with insulin. At 10
minutes incubation, a 5.7 and 5.4-fold increased phos-
phorylation was obtained at MOI1000 and 10000 (Figure
3A), and at 30 minutes incubation a 3.6 and 3.8-fold
increase in Akt phosphorylation was obtained at
MOI1000 and 10000, respectively (Figure 3C). Qualita-
tively similar data were obtained for C3A cells (Figure 3B
and 3D). Thus adenovirus infection increased basal Akt
phosphorylation and insulin was not able to increase this
further. By contrast, BacMam-transduced cells displayed
no elevated basal Akt phosphorylation and insulin was
able to induce a 1.6 to 2.1-fold activation of the enzyme,
as for control cells. The apparently smaller Akt response in
C3A cells compared to SHSY-5Y cells may be related to the
higher basal level of Akt phosphorylation in unstimulated
cells and is a feature of other hepatoma cells lines in cul-
ture including rat FAO and human HepG2 cells (data not
shown). Interestingly, when we sought to examine the
effects of virus infection on ERK1/2 activity in hepatoma
cells, we found elevated basal ERK1/2 phosphorylation
such that further increases could not be observed (data
not shown). Thus our data show that cells transduced
with baculovirus remain responsive to insulin stimulation
as measured by phosphorylation of Akt.
Discussion
In our earlier work, we reported that common lipid trans-
fection reagents are able to induce a state of cellular insu-
lin resistance which hampers significantly subsequent
experiments designed to examine insulin signal transduc-
tion [42]. We hypothesised that the activation of the insu-
lin receptor which is causal to this state of insulin
unresponsiveness is due to lipid phase separations in the
plasma membrane. In the current work, we have con-
firmed that the use of adenoviral transduction vectors in
Table 2: Transduction of neuroblastoma SHSY-5Y cells with recombinant baculovirus (BacGFP) and influence of butyrate.
w/o Butyrate With Butyrate
MOI Transduction (%)* Expression level (R.U) Transduction (%)* Expression level (R.U)
10000 33 ± n.d 4.8 82 ± n.d 21
5000 35 ± 2 4.0 77 ± 1 14
1 0 0 0 1 6  ±  53 . 35 1  ±  38 . 5
500 10 ± 2 2.6 37 ± 7 7.6
100 1.8 ± 1 1.8 16 ± 2 4.6
*Values are given with S.D. for n = 2.
Adenovirus vectors activate Akt kinase and make cells unre- sponsive to insulin Figure 2
Adenovirus vectors activate Akt kinase and make 
cells unresponsive to insulin. Cultured SHSY-5Y cells 
were treated with 100 nM insulin alone for 5 minutes (Con-
trol + Ins), or infected with recombinant adenovirus alone at 
MOI20 (AdGFP), respectively, and compared to cells simi-
larly treated with insulin but pre-infected with adenovirus 48 
h previously (AdGFP + Ins). Cells were harvested for trans-
duction efficiency and total cellular protein, and Western 
blot analyses were performed with antibodies specific for 
Akt phosphorylated on serine 473 and total Akt, respectively 
(lower panel). For quantification, densitometry of the West-
ern blot data were performed (method S.D. < 10%, n = 3).BMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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place of lipid transfection reagents leads to activation of
components of the insulin signalling PI3K pathway, with
subsequent induction of a state of insulin unresponsive-
ness. In this case, the mechanistic basis of the effects of
adenovirus transduction are better established, with the
potential involvement of integrin proteins at the cell sur-
face leading to PI3K activation [12]. Alternatively, it was
recently shown by O'Shea and co-workers that adenovirus
encodes two proteins that activate the mammalian target
of rapamycin (mTOR) and that one of these (E4-ORF1)
mimics growth factor signalling by activating PI3K [55].
In our search for transduction agents of recombinant
DNA that do not affect the cellular insulin signalling
apparatus, we examined the effects of the BacMam bacu-
lovirus vector encoding the model protein GFP. Although
known for a long time that baculoviruses can efficiently
be taken up by mammalian cells [48], the mode and
kinetics of baculovirus infection of which are poorly
understood. Recently, evidence for clathrin-mediated
endocytosis has emerged as a major entry route in mam-
malian cells [49,50]. Our data show that this vector is
effective as a transduction agent of mammalian cells in
culture and that it has no apparent effect on components
of the insulin signalling cascade leading to the activation
of PKB. As such, it does not induce a state of insulin unre-
sponsiveness and may be a promising tool for investiga-
tions of recombinantly-expressed proteins on insulin
signal transduction. Possible reasons for why BacMam
transduction avoids cellular insulin resistance would
include lack of interaction with surface integrin proteins
and the fact that the heterologous virus does not hijack
cellular protein translational machinery to the same
degree as adenovirus. It is however possible that that tran-
sient effects on PKB activation and other insulin signalling
events upon baculovirus transduction may still be possi-
ble and may occur at time points that we have not
mapped. However, the major advantage of the baculovi-
rus system is that cells remain responsive to insulin stim-
ulation showing clear activation of PKB after transduction
with the virus, which is not possible with adenovirus vec-
tors.
Interestingly, the effectiveness of BacMam as a transduc-
tion agent is greatly enhanced in the presence of the
HDAC inhibitor butyrate, which presumably leads to
enhanced chromatin modification and facilitates DNA
transcription. Differential repression of baculovirus medi-
ated transgene expression in different cell types is well
known and the use of HDAC inhibitors such as butyrate
and trichostatin A are widely use to increase gene expres-
sion [30]. Considering that HDAC2 is a negative regulator
of insulin signalling via interactions with insulin receptor
substrate proteins and that global inhibition of HDAC
activity enhances insulin signalling [51], it is unlikely that
BacMam transduction in the presence of HDAC inhibitors
will be appropriate for subsequent insulin signalling stud-
ies. However, considering the relatively benign effects of
BacMam exposure on cellular well-being, it may be possi-
ble to increase MOIs further should higher expression lev-
els of the delivered gene of interest in the studied cell line
be required. In addition, individual cell lines demonstrate
different susceptibilities to transduction by baculovirus
(Table 3) and therefore transduction conditions such as
virus dosage, temperature, viral exposure time, and trans-
duction media should be optimized for individual cell
lines in order to increase the transduction efficiency [56],
Finally, baculovirus vectors utilizing enhancer elements
such as hr1 [57] and episomal OriP/EBNA-1 elements
[58] in combination with mammalian promoters have
been shown to increase and prolong transgene expression
in mammalian cells.
Conclusion
The BacMam baculovirus vector is a promising reagent for
the transduction of mammalian cells in culture allowing
subsequent insulin signalling studies. The virus does not
induce a state of insulin unresponsiveness as do adenovi-
rus vectors and lipid transfection reagents. As such, Bac-
Mam is an agent of choice to examine the effects of
Table 3: Transduction of mammalian cell lines with BacMam at different MOI
Transduced (%)
Cells MOI 50 MOI 100 MOI 200
-But +But -But +But -But +But
CHO.hIR 0.4 50 0.8 75 1.2 91
HEK293 23 97 32 97 52 98
Fao 0.5 0.9 0.5 1.1 0.3 1.8
C 3 A 1 28 22 38 93 08 8BMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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Insulin stimulation of SHSY-5Y and C3A cells infected with adenovirus or baculovirus vectors Figure 3
Insulin stimulation of SHSY-5Y and C3A cells infected with adenovirus or baculovirus vectors. Cultured SHSY-5Y 
(A and C) and C3A (B and D) cells were transduced with adenovirus (AdGFP) at MOI10 and 50 or baculovirus (BacGFP) at 
MOI1000 and 10000, respectively, and the responsiveness to insulin was determined. Non-infected (No virus) and infected 
cells were treated with 100 nM insulin for 10 (A and B) and 30 minutes (C and D), respectively. Cells were harvested after 
incubation for total cellular protein, and ELISA was performed with antibodies specific for Akt phosphorylated on serine 473 
and total Akt, respectively.BMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
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recombinantly expressed proteins on insulin signal trans-
duction.
Methods
Materials
All cell culture reagents were from Invitrogen. Hybond-C
nitrocellulose membrane and enhanced chemilumines-
cence (ECL) were from Amersham Life Science. BCA pro-
tein analysis kit was from Pierce. Anti-phosphoserine and
protein kinase B/Akt anti-bodies and Path Scan™ total Akt
and Ser473 Phospho-Akt ELISA kits were from Cell Signal-
ling Technology.
Generation of recombinant adeno- and baculovirus
The pADTrack-CMV and pADEasy-1 plasmids, and E. coli
strain BJ5183 used to construct recombinant adenovirus
were obtained under license agreement from Dr Bert
Vogelstein, John Hopkins Oncology center, Howard
Hughes Medical Institute (Baltimore, USA) [54]. To gen-
erate the vector pMB1039, homologous recombination of
approximately 1 µg  PmeI  digested shuttle vector
(pADTrack-CMV) and 0.1 µg supercoiled ad5 backbone
vector (pAdEasy-1) was performed with 40 µl electrocom-
petent BJ5183 (endA sbcBC recBC galK met thi-1 bioT
hsdR (Strr)). The BJ5183 cells were grown to OD550 0.8,
then collected and washed twice with ice-cold 10% glyc-
erol. Electroporation was performed in 2.0 mm cuvettes at
2500 V, 200 ohms, and 25 µF in a Bio-Rad Gene Pulser
electroporator. The mixture was then plated onto agar-
kanamycin media. Only the smallest colonies were
selected for screening by restriction analysis prepared
from mini-preps. Linearized pMB1039 was subsequently
transfected into adherent HEK293A cells in MEM contain-
ing Earle's salts and glutamine and supplemented with 10
% FCS. Virus was plaque purified and subsequently prop-
agated in HEK293A cells in E-MEM supplemented with 2
% FCS. Amplified virus was purified using CsCl density
gradient ultracentrifugation essentially as described previ-
ously [52]. Isolated virus was dialysed twice in D-PBS/10
% glycerol and finally diluted in storage buffer containing
100 mM Tris-HCl (pH 8), 100 mM NaCl, 0.1 % BSA, and
50 % glycerol. Titer determination was performed by end
point dilution on HEK293 cells and adenoviral stocks
used for the experiments were typically 1010 pfu/mL.
The BacMam vector was designed essentially as described
by Condreay and coworkers [30]. To construct this vector,
a fragment containing the CMV-IE promoter/enhancer,
multiple cloning site and polyadenylation signal was iso-
lated from the pcDNA3.1+ vector (Invitrogen) by PCR
using primers 5'-CGCGTCCGGAGGGCCAGA-
TATACGCGTTGACATTG-3' (JN143) and 5'-CCCCCTA-
GAGCCCCAGCTGGTTC-3'. In parallel, a fragment
containing the SV40 promoter-neomycin phosphotrans-
ferase II expression cassette was isolated by PCR from the
pcDNA3.1+ vector using primers 5'-
GAACCAGCTGGGGCTCTAGGGGGCTGTGGAATGTGT-
GTCAGTTAGGGTGTG-3' and 5'-CCCCAAGCTTCTCA-
GAAGAACTCGTCAAGAAGGCG-3' (JN146). The
fragments were assembled by overlapping PCR using the
JN143 and JN146 primers which contains a BspEI and a
HindIII restriction site (underlined), respectively, and
inserted between BspEI and HindIII in pFastBac1 (Invitro-
gen). The constructed Bacmam vector was named
pBV973. A gene fragment encoding GFP was subsequently
inserted between KpnI and BamHI in pBV973
Recombinant BacGFP virus was generated using the Bac-
to-Bac system (Invitrogen) essentially as described [30].
Briefly, propagation of virus was performed in Sf-9 insect
cells maintained as suspension cultures in SF900-II SFM
(Invitrogen) at 27°C. For amplification to second genera-
tion virus used in the experiments, the Sf9 cells were
infected at MOI 0.1 at a cell density of 2 × 106 cells/mL. 5
days after infection, the culture medium containing
amplified virus was harvested and titres were determined
using the BacPAK baculovirus rapid titer kit (BD Bio-
sciences, Clontech, Clontechniques XII(3): 8–9, 1997). In
this titering method, a primary monoclonal antibody
raised to an AcMNPV envelope glycoprotein (gp64) was
used to label infected cells in replicate samples. A second-
ary HRP-conjugated antibody was used to stain the
infected cells so the number of infected foci could be
determined under light microscope. Viral titers between
108–109 pfu/mL were routinely obtained. Stocks of virus
for experiments in mammalian cells were concentrated by
centrifugation at 35000 × g for 60 minutes and pelleted
virus was resuspended in Dulbecco's PBS supplemented
with FBS (1 vol-%) to a final concentration of 1010 pfu/
mL.
Cell culture and treatment with adeno- and baculovirus
C3A cells were cultured in MEM supplemented with 10%
heat inactivated FCS, 1% non-essential amino acids and
1% Na-pyruvate. SHSY-5Y cells were cultured in EMEM:
Ham's F12 (1:1) supplemented with 15% heat inactivated
FCS and 1% non-essential amino acids. Both cells lines
were kept at 37°C in a humidified 5% CO2 atmosphere.
One day prior to experiment, cells were seeded out into 6
well plates (0.25 × 106 cells/well) and cultured over night.
Adeno- and Baculo-virus stocks were diluted accordingly
and added to the wells. Medium was replaced with fresh
serum-free medium after 24 h. Where indicated in Table 2
and 3 for the expression studies, 10 mM butyrate was
added to the incubation medium. After additional 24
hour incubation under serum-free conditions, medium
was replaced with fresh serum-free medium with or with-
out (control) 100 nM insulin for 10 and 30 minutes,
respectively. The plates were then placed on ice, and the
cells were washed with ice cold PBS prior to harvest, usingBMC Cell Biology 2007, 8:6 http://www.biomedcentral.com/1471-2121/8/6
Page 10 of 11
(page number not for citation purposes)
lysis buffer included in the ELISA kit (20 mM Tris-HCl, pH
7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Tri-
ton, 2.5 mM Na-pyrophosphate, 1 mM β-glycerophos-
phate, 1 mM orthovanadate, 1 µg/ml leupeptin). The lysis
buffer was supplemented with Complete™ protease inhib-
itor cocktail (Roche). As indicated in some experiments,
cells were stimulated with 100 nM human recombinant
insulin (Sigma) for 10 or 30 min prior to harvest. Lysates
were then stored at -70°C prior to analysis. Total protein
content was determined using Pierce BCA protein analysis
kit.
Sampling and analytical
For western blot analyses, samples were matched for pro-
tein concentration and heated at 70°C for 10 minutes
with reducing sample buffer. Samples were resolved on 4–
12 % gradient gels and transferred to nitrocellulose mem-
branes. Membranes were probed for the presence of total
and phosphorylated Akt using antibodies obtained from
Cell Signaling Technology, and developed using
enhanced chemoluminesence. The signal was then quan-
tified by densitometric analysis. Alternatively, total and
Ser473 phosphorylated Akt was determined with a com-
mercially available ELISA system for PKB/Akt from Cell
signalling Technology.
Flow cytometry analysis of green fluorescent protein 
expression
The flow cytometry data presented in Figure 1 and Table 3
was processed using an EPICS XL-MCL flow cytometer
(Beckman-Coulter) essentially as described previously
[42]. For the experiments in Table 2, protein expression
was measured with an Agilent 2100 Bioanalyzer using the
chip-based flow cytometry application [53]. Briefly, cul-
tures were washed with PBS, harvested with cell dissocia-
tion buffer (500 µL for 1 min) and re-suspended in 500 µL
OptiMem (Invitrogen) at room temperature. Staining for
viable cells was performed by adding carboxynaphtofluo-
rescein (CBNF, Molecular Probes, Inc., Leiden, NL) at a
final concentration of 0.5 µM. After 15 minutes, cells were
centrifuged at 500 × g for 5 minutes, followed by an addi-
tional washing and centrifuge step and finally the pellet
was re-suspended in 400 µL Cell buffer (Agilent Technol-
ogies). 10 µL cell samples were applied to the chip and
analyzed utilizing the GFP cytometry mode. Data was
obtained by gating for viable cells and adjusting for back-
ground fluorescence. Values were determined for viable
GFP expressing cells.
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